Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRT106 PIPAV vs PIPAC in Advanced Gastric Cancer
NCT07486310Phase 2Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of VRT-106 in gastric cancer (GC), peritoneal metastasis (PM), sponsored by Guangdong Provincial People's Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
VRT-106
03
Conditions
gastric cancer (GC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT07486310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486310.